FDA grants fast track status to Artiva's AlloNK for lupus nephritis
The US FDA has granted fast track designation to Artiva Biotherapeutics’ AlloNK plus rituximab or obinutuzumab, for the treatment of lupus nephritis (LN).
📰 Fred Aslan News
Fred Aslan News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Fred Aslan. Real-time updates on events, politics, business and more.
A modular pine stool wins OYOY Living Design's Togetherness Award
Danish brand OYOY Living Design is continuing its mission to create furniture and objects for the family home with its new Togetherness Award and the winners will be announced at the London Design Fair.
Source: dezeen.com
US FDA grants fast track designation to Artiva's lead programme AB-101
The US Food and Drug Administration (FDA) has granted fast track designation to clinical stage company Artiva Biotherapeutics’s lead programme AB-101.